Jiangsu Recbio Technology Co (HKSE:02179) Beta: 0.4334 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02179 Jiangsu Recbio Technology Co Ltd HKSE:02179
24 GF Score
Price HK$5.00
! 6 Warning Signs
View Full Analysis

What is Jiangsu Recbio Technology Co Beta?

Jiangsu Recbio Technology Co HKSE:02179 24 Beta is 0.4334 as of Aug. 25, 2026. GuruFocus rates HKSE:02179 with a GF Score™ of 24/100. The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-25), Jiangsu Recbio Technology Co's Beta is 0.4334.

Jiangsu Recbio Technology Co  (HKSE:02179) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Jiangsu Recbio Technology Co Beta Related Terms

Jiangsu Recbio Technology Co Beta Historical Data

* Premium members only.

The historical data trend for Jiangsu Recbio Technology Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Recbio Technology Co Beta Chart

Jiangsu Recbio Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.24

Jiangsu Recbio Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.08 0.24 0.00

HKSE:02179 vs VRTX, REGN, RVMD: Beta Comparison

For the Biotechnology subindustry, Jiangsu Recbio Technology Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Recbio Technology Co Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Recbio Technology Co's Beta distribution charts can be found below:

* The bar in red indicates where Jiangsu Recbio Technology Co's Beta falls into.


HKSE:02179
24GF Score
Jiangsu Recbio Technology Co Ltd HKSE:02179
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Recbio Technology Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.4334 mean?
Jiangsu Recbio Technology Co (HKSE:02179) has a Beta of 0.4334 as of Aug. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Jiangsu Recbio Technology Co and its competitors.
Is Jiangsu Recbio Technology Co's Beta too high?
Jiangsu Recbio Technology Co's current Beta is 0.4334. Overall, Jiangsu Recbio Technology Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Recbio Technology Co's Beta compare to VRTX and REGN?
Jiangsu Recbio Technology Co's Beta of 0.4334 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Jiangsu Recbio Technology Co and its competitors. Jiangsu Recbio Technology Co's current Beta is 0.4334. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Recbio Technology Co stock overvalued right now?
Jiangsu Recbio Technology Co (HKSE:02179) has a current Beta of 0.4334. The current Beta is 0.4334. Jiangsu Recbio Technology Co's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Jiangsu Recbio Technology Co (HKSE:02179), the current Beta is 0.4334 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jiangsu Recbio Technology Co Business Description

Other Exchanges G93:Germany
Address No. 888 Yaocheng Avenue, Medical High-tech District, Jiangsu Province, Taizhou, CHN
Jiangsu Recbio Technology Co Ltd is a vaccine company focused on the research, development, and commercialization of vaccines, with a high-value vaccine portfolio driven by in-house technologies. It has built three vaccine technology platforms: novel adjuvants, protein engineering, and immune evaluation. The company's portfolio currently consists of various vaccines, covering diseases such as cervical cancer, herpes zoster, and respiratory syncytial virus. It has two core strategic products, namely REC610, a novel adjuvanted recombinant shingles vaccine, which is currently in the stage of marketing application in China, and REC603, a recombinant HPV 9-valent vaccine under phase three clinical trial.
24GF Score

Get the complete analysis for HKSE:02179

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.00
Price